Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents.
van Haaften, Caroline
Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents. [electronic resource] - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 10 2017 - 1571-1578 p. digital
Publication Type: Case Reports; Journal Article
1525-1438
10.1097/IGC.0000000000001052 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--pharmacology
BRCA1 Protein--genetics
Cell Line, Tumor
Cisplatin--administration & dosage
Cystadenocarcinoma, Serous--drug therapy
Drug Resistance, Neoplasm
Drug Synergism
Female
Genes, BRCA1
Germ-Line Mutation
Humans
Immunohistochemistry
Lactones--administration & dosage
Ovarian Neoplasms--drug therapy
Phthalazines--administration & dosage
Piperazines--administration & dosage
Sesquiterpenes--administration & dosage
Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents. [electronic resource] - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 10 2017 - 1571-1578 p. digital
Publication Type: Case Reports; Journal Article
1525-1438
10.1097/IGC.0000000000001052 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--pharmacology
BRCA1 Protein--genetics
Cell Line, Tumor
Cisplatin--administration & dosage
Cystadenocarcinoma, Serous--drug therapy
Drug Resistance, Neoplasm
Drug Synergism
Female
Genes, BRCA1
Germ-Line Mutation
Humans
Immunohistochemistry
Lactones--administration & dosage
Ovarian Neoplasms--drug therapy
Phthalazines--administration & dosage
Piperazines--administration & dosage
Sesquiterpenes--administration & dosage